Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...

Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.

The upcoming changes raise questions for people who may still want a fall COVID-19 shot but aren't 65 or older or have at ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo shot produced a stronger immune response against COVID-19 and most strains ...

Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both ...